Original Research

Published on 09 Jun 2021

m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma

in Cancer Immunity and Immunotherapy

Junfan Pan
Zhidong Huang
Yiquan Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.657466

11,039 views
75 citations

Review

Published on 08 Jun 2021

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies

in Cancer Immunity and Immunotherapy

Maria B. Garcia-Fabiani
Santiago Haase
Andrea Comba
Stephen Carney
Brandon McClellan
Kaushik Banerjee
Mahmoud S. Alghamri
Faisal Syed
Padma Kadiyala
Felipe J. Nunez

Frontiers in Oncology

doi 10.3389/fonc.2021.631037

8,179 views
16 citations

Original Research

Published on 08 Jun 2021

Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping

in Cancer Immunity and Immunotherapy

Alec J. Kacew
Garth W. Strohbehn
Loren Saulsberry
Neda Laiteerapong
Nicole A. Cipriani
Jakob N. Kather
Alexander T. Pearson

Frontiers in Oncology

doi 10.3389/fonc.2021.630953

9,333 views
38 citations

Original Research

Published on 04 Jun 2021

Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma

in Cancer Immunity and Immunotherapy

Liuning Li
Guojie Lu
Yang Liu
Longlong Gong
Xue Zheng
Hongbo Zheng
Weiguang Gu
Lin Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.658690

4,956 views
18 citations

Original Research

Published on 04 Jun 2021

The Application of Combined Immune Checkpoint Inhibitor Modalities in Previously Treated Non-Small Cell Lung Cancer Patients and the Associations Thereof With the Lung Immune Prognostic Index

in Cancer Immunity and Immunotherapy

Ting Zhang
Xue Yang
Jing Zhao
Lixia Xia
Qiyuan Wang
Rui Jin
Lingxiao Zhou
Bin Zhang
Jun Zhao
Huijie Li

Frontiers in Oncology

doi 10.3389/fonc.2021.690093

3,147 views
7 citations

Original Research

Published on 04 Jun 2021

PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer

in Cancer Immunity and Immunotherapy

Peiwen Fan
Xi Li
Yaning Feng
Hongchao Cai
Danning Dong
Yanchun Peng
Xuan Yao
Yuping Guo
Miaomiao Ma
Tao Dong

Frontiers in Oncology

doi 10.3389/fonc.2021.678758

4,198 views
13 citations

Original Research

Published on 01 Jun 2021

Spi-B Promotes the Recruitment of Tumor-Associated Macrophages via Enhancing CCL4 Expression in Lung Cancer

in Cancer Immunity and Immunotherapy

Qiumin Huang
Junrong Liu
Shuainan Wu
Xuexi Zhang
Zengtuan Xiao
Zhe Liu
Wei Du

Frontiers in Oncology

doi 10.3389/fonc.2021.659131

4,407 views
11 citations

Review

Published on 31 May 2021

Immunological Effects of Histotripsy for Cancer Therapy

in Cancer Immunity and Immunotherapy

Alissa Hendricks-Wenger
Ruby Hutchison
Eli Vlaisavljevich
Irving Coy Allen

Frontiers in Oncology

doi 10.3389/fonc.2021.681629

21,186 views
45 citations

Original Research

Published on 31 May 2021

Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Teng Li
Xiaocong Pang
Junyun Wang
Shouzheng Wang
Yiying Guo
Ning He
Puyuan Xing
Junling Li

Frontiers in Oncology

doi 10.3389/fonc.2021.591922

4,607 views
13 citations

Original Research

Published on 31 May 2021

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

in Cancer Immunity and Immunotherapy

Yuan-Hung Kuo
Yi-Hao Yen
Yen-Yang Chen
Kwong-Ming Kee
Chao-Hung Hung
Sheng-Nan Lu
Tsung-Hui Hu
Chien-Hung Chen
Jing-Houng Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.683341

3,743 views
18 citations

Review

Published on 31 May 2021

Toxicities of Immunotherapy for Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Yang Fu
Yue Zheng
Pei-Pei Wang
Zhen-Yu Ding

Frontiers in Oncology

doi 10.3389/fonc.2021.603658

8,009 views
8 citations

Original Research

Published on 28 May 2021

The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study

in Cancer Immunity and Immunotherapy

Keiko Tanimura
Tadaaki Yamada
Ayaka Omura
Shinsuke Shiotsu
Nobutaka Kataoka
Takayuki Takeda
Ryusuke Taniguchi
Takahiro Yamada
Mayumi Takeuchi
Yusuke Chihara

Frontiers in Oncology

doi 10.3389/fonc.2021.663612

5,952 views
8 citations

Case Report

Published on 28 May 2021

Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report

in Cancer Immunity and Immunotherapy

Yuhan Wang
Rongchun Lin
Bingzhong Zhang
Hui Zhou
Zhongqiu Lin
Tingting Yao

Frontiers in Oncology

doi 10.3389/fonc.2021.598594

3,080 views
6 citations

Review

Published on 28 May 2021

Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment

in Cancer Immunity and Immunotherapy

Juan-Yan Liao
Shuang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.663264

7,477 views
28 citations

Case Report

Published on 28 May 2021

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Xiaojie Zhang
Hao Huang
Lu Han
Tiepeng Li
Zibing Wang
Quanli Gao

Frontiers in Oncology

doi 10.3389/fonc.2021.640447

3,316 views
4 citations

Systematic Review

Published on 27 May 2021

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Jiexuan Hu
Ruyue Tian
Yingjie Ma
Hongchao Zhen
Xiao Ma
Qiang Su
Bangwei Cao

Frontiers in Oncology

doi 10.3389/fonc.2021.645245

4,674 views
20 citations

Navigation group

Articles

m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies

Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping

Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma

The Application of Combined Immune Checkpoint Inhibitor Modalities in Previously Treated Non-Small Cell Lung Cancer Patients and the Associations Thereof With the Lung Immune Prognostic Index

PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer

Spi-B Promotes the Recruitment of Tumor-Associated Macrophages via Enhancing CCL4 Expression in Lung Cancer

Immunological Effects of Histotripsy for Cancer Therapy

Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Toxicities of Immunotherapy for Small Cell Lung Cancer

The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study

Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report

Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis